EMA’s Emer Cooke On The Future Of Rolling Reviews & The End Of Remote Meetings
Emer Cooke, executive director of the European Medicines Agency, has offered some insights into how the agency’s working may change following the COVID-19 pandemic, including the development of hybrid inspections.
You may also be interested in...
The European Medicines Agency is expecting a lively pipeline of advanced therapy medicines over the next few years. It is also making final preparations for the introduction of the new EU clinical trials system from the end of January next year.
The European Parliament and EU Council have reached an agreement on taking forward proposals for greater cooperation on health technology assessments.
The norms on securing market access are being rewritten for cell and gene therapies.